Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-04-12
1993-09-07
Russell, Mark
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514445, 514826, 549 64, 549 65, 549313, 549314, 549316, 549317, A61K 31365, A61K 3138, C07D30733, C07D33332
Patent
active
052429458
ABSTRACT:
There are disclosed compounds of the formula: ##STR1## wherein X is --CH.sub.2 R;
REFERENCES:
patent: 4874782 (1989-10-01), Bonjouklian et al.
Kataoka, et al., Chemical Abstracts 84:175, 144m, English abstract of Japanese patent 51-1633, p. 174 (1976).
Omo et al., Chemical Abstracts 81:151976w, English abstract of Japanese patent 49-69659, pp. 510-511 (1974).
Foye, "Principles of Medicinal Chemistry," 2nd ed., pp. 80-83 Lea & Febiger, Philadelphia (1981).
B. Potts et al., J. Am. Chem. Soc., 114, pp. 5093-5100 (1992).
"The Pharmacological Basis of Therapeutics", A. Gillman et al. ed., 6th ed., pp. 685, 1979-1480, and 1489-1490, MacMillan Publishing Co., New York (1980).
Remington's "Pharmaceutical Sciences," J. Hoover ed., 14th ed., Mack, pp. 1163-1173 Publishing Co., Easton, Penn. (1970).
L. Reynolds, et al., J. Am. Chem. Soc., "Phospholipose A.sub.2 Inhibition and Modification by Monoalogue," 110, pp. 5172-5177 (1988).
L. Reynolds, et al., J. Biol. Chem., "Inhibition of Venom Phospholipose A.sub.2 by Monolide and Manoalogue," 266 (75), 16512-16517 (1991).
C. Bennett et al., Biochem. Pharmacol., "Differential Effect of Manolide on Secreted and Intracellular Properties," 36 (5), pp. 733-740 (1987).
Nemura et al. Chem. Bull. Pharm., 34(12), 5188-90 (1986).
Tanaka et al. Chem. Bull. Pharm., 27(8), 1901-1906 (1978).
Caufield Craig E.
Rinker James M.
American Home Products Corporation
Russell Mark
Tarnowski George
LandOfFree
Tetronic and thiotetronic acid derivatives as phospholipase A.su does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetronic and thiotetronic acid derivatives as phospholipase A.su, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetronic and thiotetronic acid derivatives as phospholipase A.su will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-488130